| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/18/2005 | CN1615853A Enhancement of bone growth and inhibition of bone resorption |
| 05/18/2005 | CN1615848A Troxerutin-coumarin dripping pill |
| 05/18/2005 | CN1615847A Use of scopoletin in preparing medicine for preventing and curing hyperuricemia |
| 05/18/2005 | CN1615839A Utilization of dialkylfumarates |
| 05/18/2005 | CN1202130C Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method |
| 05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
| 05/18/2005 | CN1202096C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1202068C Aspirin-triggered lipid mediators |
| 05/18/2005 | CN1201826C Method for preparing high activity bone defect repairing material |
| 05/18/2005 | CN1201812C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 05/18/2005 | CN1201804C Medicine for treating osteoporosis and its preparation method |
| 05/18/2005 | CN1201800C Medicinal liquor for curing traumatic injury and rhematalgia and preparing method thereof |
| 05/18/2005 | CN1201799C Chinese medicine preparation for curing osteoporosis preparing method thereof |
| 05/18/2005 | CN1201791C External plaster for treating rheumatic arthralgia and its preparing method |
| 05/18/2005 | CN1201779C Medicine for curing setting of fracture |
| 05/18/2005 | CN1201766C External use plaster for curing cervical spondylopathy |
| 05/18/2005 | CN1201765C Chinese medicine ointment for treating arthrosis |
| 05/18/2005 | CN1201764C Chinese medicine oil preparation for promoting blood circulation |
| 05/18/2005 | CN1201757C Chinese medicine for treating bone fracture |
| 05/18/2005 | CN1201749C Vaginal delivery of bisphosphonates |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |
| 05/17/2005 | US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases |
| 05/17/2005 | US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
| 05/17/2005 | US6894038 Administering an estriol 3,17-dipropionate or an estriol 3,17-dihexanoate, for treating multiple sclerosis |
| 05/17/2005 | US6894036 4-dedimethylaminotetracycline derivatives |
| 05/17/2005 | US6894027 Stimulation of bone growth with thrombin peptide derivatives |
| 05/17/2005 | US6893838 DADD, death activator death domain protein |
| 05/17/2005 | US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 05/17/2005 | CA2335492C Pyrrolo[2,3-d]pyrimidine compounds |
| 05/17/2005 | CA2306782C Isoquinolines as urokinase inhibitors |
| 05/17/2005 | CA2126327C Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 05/12/2005 | WO2005042727A2 Methods of organ regeneration |
| 05/12/2005 | WO2005042482A1 Vitamin d3 lactam derivative |
| 05/12/2005 | WO2005016514A3 Combinatorial synthesis on support |
| 05/12/2005 | WO2005007699A3 Human antibody molecules for il-13 |
| 05/12/2005 | WO2005002572A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 05/12/2005 | WO2005000231A3 Il-8 receptor antagonists |
| 05/12/2005 | WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/12/2005 | US20050101769 CD40-interacting and TRAF-interacting proteins |
| 05/12/2005 | US20050101664 Anionically coupling an acyl imidazoyl carbamate with a primary amide or carbamate; N-alkylation; inosine-5*-monophosphate dehydrogenase inhibitors |
| 05/12/2005 | US20050101662 Such as coumarin, dicoumarol, 7-hydroxycoumarin (umbelliferone), 6,7- dihydroxycoumarin (exculetin), 3,6,7 trihydroxycoumarin, warfarin, or warfarin sodium; cancer, Alzheimer's disease, gout, atherosclerosis, restenosis |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
| 05/12/2005 | US20050101593 Phosphoric acid salt of an integrin receptor antagonist |
| 05/12/2005 | US20050101591 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 05/12/2005 | US20050101584 Selective estrogen receptor-beta ligands |
| 05/12/2005 | US20050101577 2-alkylidene-19-nor-vitamin D derivatives for the treatment of rickets or vitamin D deficiency |
| 05/12/2005 | US20050101575 Vitamin d3 derivatives and remedies using the same |
| 05/12/2005 | US20050101567 Using a sulfonamide containing compound |
| 05/12/2005 | US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders |
| 05/12/2005 | US20050101557 Immunostimulatory nucleic acid molecules |
| 05/12/2005 | US20050101554 Methods for treating and preventing infectious disease |
| 05/12/2005 | US20050101536 Modulation of angiogenesis |
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors |
| 05/12/2005 | US20050100894 Novel mitogen activated kinase |
| 05/12/2005 | US20050100617 Method for improving age-related physiological deficits and increasing longevity |
| 05/12/2005 | US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response |
| 05/12/2005 | US20050100536 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
| 05/12/2005 | CA2544725A1 Vitamin d3 lactam derivative |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543608A1 Pyrimidines as inhibitors of phosphoinositide -3-kinases (pi3k) |
| 05/11/2005 | EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/11/2005 | EP1257526B1 Aniline-derived ligands for the thyroid receptor |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1140124B1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615299A Xanthine oxidase inhibitors |
| 05/11/2005 | CN1615149A Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/11/2005 | CN1615148A Methods and compositions for derepression of IAP-inhibited caspase |
| 05/11/2005 | CN1615140A Polynucleotide therapy |
| 05/11/2005 | CN1613874A Human tumour necrosin antibody, its preparation and medicinal composition |
| 05/11/2005 | CN1613479A Quick effective heat-reducing and bone numbness releasing medicine |
| 05/11/2005 | CN1613471A Preparation of compound pseudo-ginseng drop pellets for treating traumatologic disease |
| 05/11/2005 | CN1613469A Medical pillow |
| 05/11/2005 | CN1613463A External applied Chinese medicinal paste for treating arthralgia |
| 05/11/2005 | CN1613460A Bone nourishing and rheumatic treating pills and their preparation |
| 05/11/2005 | CN1613458A Medicinal composition for treating hypersteogeny |
| 05/11/2005 | CN1200951C Process for productio nof multiple cross-linked hyaluronic acid derivatives |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200728C Injection-type bone morphogenetic protein using fibrin as carrier |
| 05/11/2005 | CN1200724C Pill for activating collateral flow and removing spur |
| 05/11/2005 | CN1200714C Use of diterpenoid triepoxides as anti-proliferative agent |
| 05/11/2005 | CN1200704C Appliance of probucol monoesters for treatment of cardiovascular and inflammatory disease |
| 05/11/2005 | CN1200691C Oral solution containing galanthamine and sweetening agent |
| 05/10/2005 | US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 05/10/2005 | US6891062 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass |
| 05/10/2005 | US6891039 2-(4-Fluorophenyl)-1-(2-cyclopentylamino-4-pyrimidinyl)-5-(piperidino-N -2-ethyl)imidazo(4,5-b)pyridine, for example; MAP kinase inhibitors, for Tumor Necrosis Factor (TNF-alpha) and Interleukin-1 (IL-1) disorders such as osteoporosis |
| 05/10/2005 | US6890938 Antiinflammatory agents |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890929 Immunosuppressants; lupus, multiple sclerosis, skin disorders, antiarthritic agents, antihistamines, antiulcer agents, Crohn's disease |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |